Amoun Pharmaceutical Company: A Leading Force in Egyptian Healthcare

Amoun Pharmaceutical Company, a prominent Egyptian Joint-Stock Company established in 1998, has become a leading force in the country’s healthcare sector. With a unwavering commitment to providing high-quality pharmaceutical products and exceptional patient care, Amoun has carved a niche for itself through its dedication to innovation and exceptional service.

This blog post dives deep into the world of Amoun Pharmaceutical Company, exploring its rich history, core values, and commitment to excellence. We’ll also shed light on its impressive growth trajectory, strategic advantages, and unwavering dedication to patient safety. So, whether you’re a patient seeking information about a reputable pharmaceutical company in Egypt, or an industry professional curious about a leader in the region, this post is for you!

Quick Links

• Amoun Pharmacovigilance Group Contact Details
• Amoun Headquarters
• Amoun Regional Offices
• Amoun International Office
• Amoun Product Portfolio

About Amoun Pharmaceutical Company

Amoun’s story is one of dedication and continuous improvement. Founded in 1998 with a mission to provide essential pharmaceutical therapies and treatments, the company has grown into a multifaceted organization encompassing the entire pharmaceutical value chain. This means Amoun oversees every stage of a drug’s journey, from its development and manufacturing to marketing, distribution, and export.

A Legacy of Excellence

Driven by a core focus on quality and patient well-being, Amoun prioritizes providing essential medications to both local and global communities. Their commitment to ethical practices and a patient-centric approach has fueled their success over the years.

Unmatched Growth and Achievements

Amoun’s dedication to quality and innovation has translated into impressive growth and achievements. In 2023, the company reached a remarkable milestone with sales reaching a staggering 5.7 billion Egyptian Pounds. This not only signifies Amoun’s consistent growth trajectory but also stands as a testament to their unwavering commitment to excellence.

Furthermore, Amoun boasts a Compound Annual Growth Rate (CAGR) of 18% over the past five years. This impressive statistic highlights the company’s ability to thrive in a highly competitive market, constantly adapting and innovating to meet evolving healthcare needs.

Amoun’s growth can be attributed to several factors, including:

• A Robust Product Pipeline: Amoun maintains a strategically designed product pipeline that is continuously expanding. This pipeline ensures the company can address the ever-changing needs of the healthcare sector and offer patients a wider range of treatment options.
• Focus on Quality and Safety: Amoun prioritizes the highest standards of quality and safety throughout the entire manufacturing process. This commitment ensures patients receive effective and reliable medications.
• Strategic Partnerships: Amoun’s affiliation with prominent entities like ADQ, a leading Abu Dhabi-based investment and holding company, provides them with access to additional resources and expertise. This collaboration fuels further growth and innovation.

Strategic Advantages for Unwavering Quality

Amoun’s position as a leader in the Egyptian pharmaceutical industry is bolstered by several strategic advantages that ensure the consistent delivery of high-quality healthcare products. Here are some key aspects that contribute to their success:

• State-of-the-Art Manufacturing Facilities: Amoun takes pride in owning one of the largest and most advanced pharmaceutical manufacturing facilities in Africa and the Middle East. This facility is equipped with cutting-edge technology that allows for the production of medications adhering to the strictest global standards.
• Strategically Located Headquarters: Amoun’s headquarters are strategically situated in El-Obour City, Egypt. This central location allows for efficient distribution throughout the country, ensuring timely access to essential medications for patients across Egypt.
• Affiliation with ADQ: Amoun’s association with ADQ, a prominent Abu Dhabi-based investment and holding company, is a significant advantage. This affiliation provides Amoun with several benefits, including:
  • Access to Additional Resources: ADQ’s vast resources empower Amoun to invest in further research and development, expand their product portfolio, and explore new market opportunities.
  • Expertise and Collaboration: The partnership with ADQ allows Amoun to leverage the expertise and experience of industry leaders, fostering innovation and propelling the company forward.
  • Shared Commitment to Progress: Both Amoun and ADQ share a commitment to driving innovation and progress within the healthcare sector. This shared vision fuels advancements that ultimately benefit patients and contribute to the betterment of communities.

By combining these strategic advantages, Amoun is able to maintain its position at the forefront of the Egyptian pharmaceutical industry. Their commitment to quality and innovation ensures a consistent supply of reliable and effective medications for patients across the region.

A Committed Leadership and Transformation

Since December 2012, Amoun Pharmaceutical Company has undergone a remarkable transformation under the guidance of its dedicated leadership team. This transformation involved a strategic shift that has positioned Amoun as a preferred partner for various stakeholders within the healthcare ecosystem.

Let’s delve deeper into this transformation and how it has impacted Amoun’s standing:

• Shifting Focus: Prior to 2012, Amoun primarily focused on its role as a manufacturer of high-quality pharmaceuticals. However, the leadership team recognized the potential for Amoun to play a more prominent role within the industry. This led to a strategic shift towards becoming a comprehensive partner.
• Expanding Partnerships: Amoun actively sought collaborations with innovators, multinationals, regulators, and local communities. This broadened their reach and allowed them to contribute more significantly to the overall healthcare landscape in Egypt.
• Building Trust and Influence: Through their commitment to quality, innovation, and collaboration, Amoun has earned the trust and respect of industry leaders and patients alike. This has solidified their position as a frontrunner in the Egyptian pharmaceutical industry.

Amoun’s leadership team continues to spearhead the company’s growth and development. Their commitment to a clear vision and mission has propelled Amoun forward, establishing them as a trusted partner within the Egyptian healthcare sector.

Amoun’s Dedication to Patient Safety

Patient safety is paramount in the pharmaceutical industry. Ensuring that medications are effective, reliable, and don’t cause undue harm is a top priority for any reputable pharmaceutical company. Amoun understands this critical aspect and has implemented a robust system to prioritize patient safety throughout the entire product lifecycle.

Here’s a closer look at Amoun’s commitment to patient safety:

• Pharmacovigilance Group: Amoun established a dedicated Pharmacovigilance Group specifically focused on monitoring the safety of their medications. This group actively collects and analyzes data on potential adverse effects associated with Amoun’s products.
• Rigorous Quality Control: Amoun adheres to stringent quality control measures throughout the manufacturing process. This includes implementing best practices and employing cutting-edge technology to ensure the quality and consistency of their medications.
• Transparency and Communication: Amoun prioritizes open communication with healthcare professionals and patients. They actively share information about their medications, including potential side effects and safety precautions. Additionally, Amoun’s Pharmacovigilance Group promptly addresses any reported safety concerns and takes necessary actions to ensure patient well-being.

By prioritizing patient safety, Amoun demonstrates its commitment to ethical practices and responsible healthcare. Their dedication to this crucial aspect fosters trust among patients and healthcare professionals alike.

A Look Back: Amoun’s Rich History

Amoun’s journey to becoming a leading force in the Egyptian pharmaceutical industry is a story of perseverance, innovation, and a steadfast commitment to healthcare. Let’s explore some of the key milestones that have shaped Amoun’s remarkable history:

• 1998: A Legacy Begins
  • Amoun Pharmaceutical Company was founded in 1998 by Dr. Tharwat Bassily with a vision to provide essential pharmaceutical therapies to the Egyptian community.
  • Established in El Obour City, Egypt’s first industrial zone designed by John Brown Co. in Chicago, USA, Amoun’s strategic location facilitated efficient production and distribution.
• 2006: A Catalyst for Growth
  • In 2006, Amoun was acquired by a consortium of financial investors, including CVCI Private Equity Fund (acquired by Rohatyn Group), Capital International Private Equity L.P., and Concord International.
  • This acquisition provided Amoun with a significant financial boost, allowing them to invest in expanding their product portfolio and production capabilities.
• 2015: Expanding Horizons
  • The year 2015 marked another significant milestone for Amoun with its acquisition by Bausch Health (formerly Valeant Pharmaceuticals International Inc.).
  • This acquisition provided Amoun with access to Bausch Health’s global network and expertise, further propelling their growth and international reach.
• 2021: A New Era of Partnership
  • In 2021, Amoun embarked on a new chapter with its acquisition by ADQ, a prominent Abu Dhabi Holding Company.
  • This strategic partnership provided Amoun with substantial resources and expertise, solidifying their position as a key player in the regional pharmaceutical landscape.

Amoun’s history reflects a continuous drive for growth and innovation. Each acquisition and milestone has played a crucial role in shaping the company into the leading Egyptian pharmaceutical force it is today.

Reaching Out to Amoun Pharmaceutical Company

Amoun Pharmaceutical Company offers various channels for communication, making it easy for patients, healthcare professionals, and other stakeholders to connect with them. Here’s a breakdown of their contact information:

Amoun Regional Offices

Amoun maintains a presence across various Egyptian cities to serve patients and healthcare professionals effectively. Here are some of their regional office details:

* We recommend visiting the Amoun website (https://www.amoun.com/) for a complete list of regional office addresses and contact information

Amoun International Office

*Dubai – UAE Office (Contact details for the Dubai office can be found on the Amoun website: https://www.amoun.com/)

AMOUN PHARMACEUTICAL CO. – Contact Information

Website & Social Media

For the most up-to-date information on Amoun Pharmaceutical Company, including their product portfolio, services, and news updates, visiting their official website is highly recommended ( https://www.amoun.com/). The website likely offers contact forms or email addresses for specific inquiries.

* Amoun Page on Facebook: facebook@Amoun Pharmaceutical Co. S.A.E 

Amoun product portfolio

Category: Analgesics, NSAIDs

1. Ketlgin® [ketoprofen] – Analgesic, Antipyretic, Anti-Inflammatory
2. Ketolgin® Gel: Topical Pain Relief for Musculoskeletal Conditions
3. Ketolgin® Ampoules: Injected Pain Relief for Acute Conditions
4. Ketolgin® Suppositories: Pain Relief for Various Conditions
5. Ketolgin® Tablets 25,50 & S.R. capsules (200 mg)
6. Amoflam® 100 mg enteric coated tablet 

Category: Opioid analgesic

1. Nalufin® Ampoules: to Relief for Moderate to Severe Pain

Category: Drug for Neuropathic pain

1. IRENYPATHIC 75, 150 mg Hard Gelatin Capsules
2. Irenypathic Capsules (Pregabalin): Effective Relief for Neuropathic Pain

Category: Anti-histamines

1. Mosedin Plus SR Capsules
2. Mosedin® (Loratadine)
3. Mosedin® [Loratadine] – Nonsedating, Long Acting Anthistamine
4. Mosedin Syrup 5 mg/5 ml
5. Mosedin Oral Tablets To Relieve Allergy Symptoms
6. Mosedin Plus SR Sustained Release Capsules
7. Mosedin Tablets & Syrup- Loratadine
8. Allerfen® (Fexofenadine)
9. Allerfen®- Non sedating Third Generation Antihistamine

Category: Antibacterial drugs, Anti-infectives

1. Fortibiotic® (Ampicillin/Sulbactam)
2. Fladazole® [secnidazole] For Treatment Of Amebiasis, Trichomoniasis & Giardiasis
3. Fladazole® (Secnidazole): Treating Parasitic Infections

Category: Anti-inflammatory enzymes

1. Alphintern® Explained: An In-Depth Look at Anti-inflammatory Enzymes
2. Alpha Chymotrypsin Injections
3. Alphintern® gastroresistant and enterosoluble coated tablet
4. α- chymotrypsin® injectable
5. Alphintern – Anti-inflammatory and anti-edematous

Category: Cardiovascular drugs

1. kapron tablets & ampoules
2. Kapron® Tablets (Tranexamic Acid): for Bleeding and Blood Clot Management
3. Kapron® Ampoules : Injectable Medication for Managing Bleeding
4. Valsatens®- Medication for Heart Health
5. Valsatens Plus®: for Managing High Blood Pressure

Category: Centrally acting Drugs

1. Amotril® [clonazepam] tablets – Antiepileptic
2. Amotril® (Clonazepam): Epilepsy Medication
3. No-Migraine Z® (Zolmitriptan): A Fast-Acting Option for Migraine Relief
4. Hyponor® [zopiclone] – Hypnotic-sedative
5. No-migrain Z orally disintegrating tablet – Fast relief of Migraine
6. Hypnor® Tablets (Zopiclone) for Insomnia Relief
7. Midazolam (Midathetic®) for Anxiety or Sleep Problems
8. No-Migrain® tablets – Treatment of Migraine

Category: Drugs for oral cavity

1. B.B.C.® – Antiseptic, Anti-inflammatory, Analgesic and Local Anesthetic For Mouth and Throat
2. B.B.C. Mouth and Throat Spray (Local Anesthetic, Antiseptic)

Category: Drugs for respiratory system

1. Clear air 4 mg Chewable Tablets
2. Clear air 5 mg Chewable Tablets
3. Neo Michaelon® Suspension: Relief for Cold and Flu Symptoms
4. Montelukast (Clear Air®) for Asthma, Allergies
5. Michaelon® tablets For Flu and Common cold
6. Relief from Common Cold and Flu Symptoms with Neo Michaelon®
7. Relief from Cough and Mucus with Ultrasolv®
8. Ultrasolv® syrup – Mucolytic and Expectorent
9. Clear Air® Breathe Easier with Montelukast

Category: Drugs for Urinary Disorders

1. Urivin® Effervescent Granules
2. Tamsulosin (Tamsul) for Benign Prostatic Hyperplasia (BPH)

Category: Vitamins, minerals, drugs for anemia

1. VITAMOUNT® SYRUP: MULTIVITAMIN SYRUP FOR CHILDREN

Category: Gastrointestinal drugs

1. Viscera syrup- Tiemonium methyl sulfate( 10mg/ 5ml).
2. Viscera ampoules- Tiemonium methyl sulfate( 5mg/ 2ml).
3. Emetrex: Relieving Nausea, Vomiting, and Vertigo
4. Emetrex® tablets For Nausea, Vomting and Vertigo
5. Em-Ex® (Granisetron): Effective Relief for Nausea and Vomiting
6. Antodine® [famotidine]- For Treatment Of Hyperacidity, Gastroesophageal Reflux and Peptic Ulcer
7. Antodine Ampoules (Famotidine Injection): Effective Relief for Peptic Ulcers and GERD
8. Emetrex® Ampoule: Medication for Nausea and Vomiting
9. My-Sweet Baby N Syrup.

Conclusion

Amoun Pharmaceutical Company has carved a niche for itself in the Egyptian healthcare sector. Through their unwavering commitment to quality, innovation, and patient safety, Amoun has established itself as a leading force in the region. Their dedication to ethical practices, collaboration, and continuous improvement ensures a reliable supply of essential medications for patients across Egypt.

We hope this blog post has provided you with a comprehensive overview of Amoun Pharmaceutical Company. For further information, we encourage you to explore Amoun’s website or contact them directly through the provided channels.

---

* Contact Us: If you have any notes or feedback you need to reach us with, feel free contacting us any time via e-mail( [email protected]). Please contact us via email ([email protected]) or via contact us form, if the information on this page is incorrect, or if you have other information to update this page.